Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aequus Pharmaceuticals Inc (AQS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8289
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aequus Pharmaceuticals Inc (Aequus Pharmaceuticals) is a drug discovery and development company that develops differentiated drugs. The company’s pipeline products include AQS301, AQS302 and AQS303. Its commercial pipeline comprises ophthalmology products and transplant products. Aequus Pharmaceuticals develops products in the areas of neurology and psychiatry with addressing the need for improved medication through enhanced delivery systems. The company offers its products to hospital specialty markets including patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas across Canada. It offers its products in therapeutic areas such as ophthalmology, neurology, and transplant. Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia, Canada.

Aequus Pharmaceuticals Inc (AQS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises US$1.2 Million In First Round Of Venture Financing 14
Partnerships 15
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Licensing Agreements 22
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Equity Offering 25
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Acquisition 38
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc – Key Competitors 39
Aequus Pharmaceuticals Inc – Key Employees 40
Aequus Pharmaceuticals Inc – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
May 31, 2018: Aequus Provides First Quarter 2018 Financial and Corporate Highlights 42
Apr 27, 2018: Aequus Pharmaceuticals Reports Fourth Quarter and Fiscal 2017 Financial Highlights 44
Nov 29, 2017: Aequus Provides Third Quarter 2017 Operational Highlights 47
Aug 29, 2017: Aequus Provides Second Quarter 2017 Operational Highlights 49
May 30, 2017: Aequus Provides First Quarter 2017 Financial Highlights 51
May 01, 2017: Aequus Provides Fourth Quarter and Fiscal 2016 Financial Highlights 52
Product News 54
09/07/2017: Aequus Announces Positive Results for Proof of Concept Clinical Trial of Anti-Nausea Patch 54
04/03/2017: Aequus Announces Positive Results from Second Proof of Concept Study for Long-Acting Aripiprazole Transdermal Patch 55
02/01/2017: Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development 56
Product Approvals 57
Mar 07, 2018: FDA Confirms Date to Providing Regulatory Guidance for Aequus’ Anti-Nausea Patch 57
Jan 31, 2018: Aequus and Camargo Prepare for Meeting with FDA to Advance Anti-Nausea Patch 58
Aug 24, 2017: Aequus Announces Abbreviated Development Path for Transdermal Aripiprazole 59
Jun 15, 2017: Aequus Advances Clinical Development of Transdermal Anti-Nausea Patch 60
Jan 09, 2017: Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 61
Clinical Trials 62
Jul 05, 2017: Aequus Receives Approval from Health Canada to Initiate Proof of Concept Clinical Trial of Anti-Nausea Patch 62
Feb 14, 2017: Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch 63
Appendix 64
Methodology 64
About GlobalData 64
Contact Us 64
Disclaimer 64

List of Tables
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Aequus Pharma Raises USD0.6 Million in Venture Financing 13
Aequus Pharma Raises US$1.2 Million In First Round Of Venture Financing 14
Aequus Pharma Enters into Agreement with Ehave 15
CannaRoyalty and Aequus Pharma Enter into Agreement 16
Aequus Pharma to Enter into Agreement with Scientus Pharma 17
Aequus Pharma Enters into Agreement with Santen 18
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 19
Aequus Pharma Enters into Co-Development Agreement with Corium International 20
Aequus Pharma Enters into Co-Development Agreement with Corium International 21
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 22
Aequus Pharma Enters into Licensing Agreement with Supernus Pharma 23
Aequus Pharma Enters Into Licensing Agreement With Transdermal Research Pharm Labs For Transdermal Delivery Of Aripiprazole 24
Aequus Pharma Raises USD0.2 Million in Private Placement of Units 25
Aequus Pharma Raises USD0.6 Million in Private Placement of Units 26
Aequus Raises USD0.2 Million in Private Placement of Units 28
Aequus Pharma Plans to Raise up to USD15.7 Million in Public Offering 29
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 30
Aequus Pharma Raises USD2 Million in Public Offering of Shares 32
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 33
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 34
Aequus Pharma Raises USD1 Million in Public Offering of Shares 35
Aequus Pharma Raises USD3.3 Million in Private Placement of Warrants 36
Aequus Pharma Raises USD0.4 Million in Private Placement of Warrants 37
Aequus Pharma Acquires TeOra Health 38
Aequus Pharmaceuticals Inc, Key Competitors 39
Aequus Pharmaceuticals Inc, Key Employees 40
Aequus Pharmaceuticals Inc, Subsidiaries 41

List of Figures
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Aequus Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Aequus Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Aequus Pharmaceuticals Inc (AQS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TiGenix NV (TIG):企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing a …
  • Therabron Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therabron Therapeutics Inc (Therabron), formerly Clarassance Inc is a clinical-stage biopharmaceutical company that develops drugs based on secretoglobin family of proteins. The company’s lead biopharmaceutical candidate includes CG100, CG201, CG367, CG459 and CG1011. Its CC10 protein candid …
  • Concordia International Rx UK Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Concordia International Rx UK Ltd (Concordia) formerly Amdipharm Mercury Company Ltd, a subsidiary of Concordia International Corp, is a manufacturer of pharmaceutical products and orphan drugs. The company’s products include acetazolamide, adenosine, adrenaline acid tartrate, alfacalcidol, …
  • ABB, Ltd.:企業の戦略・SWOT・財務情報
    ABB, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ABB, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Castlight Health Inc (CSLT):医療機器:M&Aディール及び事業提携情報
    Summary Castlight Health Inc (Castlight) provides an online health navigation platform that connects patients with health vendors, plan designs, and benefit resources. The platform allows patients to view and compare the prices of medical services and surgeries from multiple health providers. It off …
  • Arab National Bank:企業の戦略・SWOT・財務情報
    Arab National Bank - Strategy, SWOT and Corporate Finance Report Summary Arab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Public Service Enterprise Group Inc (PEG)-エネルギー分野:企業M&A・提携分析
    Summary Public Service Enterprise Group Inc. (PSEG) is a diversified energy holding company that generates, transmits and distributes electricity, and gas. It supplies electricity from its nuclear, fossil and renewable energy assets as part of its wholesale energy activities. The company sells elect …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …
  • TPF SA:企業の戦略的SWOT分析
    TPF SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Arcadia Biosciences Inc (RKDA):企業の財務・戦略的SWOT分析
    Summary Arcadia Biosciences Inc (Arcadia) is an agricultural and clean technology company that develops and commercializes agricultural products. Its major products include goodwheat branded ingredients, nutritional oils, animal nutrition and agricultural products. The company's products exhibit tra …
  • Union Electrica SA:企業の戦略的SWOT分析
    Union Electrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bayer AG (BAYN):企業の財務・戦略的SWOT分析
    Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Gavilon Agriculture Holdings Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Gavilon Agriculture Holdings Co (Gavilon) is a merchandising service provider that offers essential agricultural commodities and services. The company’s products include grains and oilseeds, feed ingredients, fertilizers, and food ingredients, among others. Its feed ingredients comprise anim …
  • JX Nippon Oil & Energy Corporation-エネルギー分野:企業M&A・提携分析
    Summary JX Nippon Oil & Energy Corporation (JXNOE) is a downstream refining company. The company refines and markets petroleum and petrochemical products. Its products include petrochemicals, lubricants, optical films, greases, fluids, engine oils, composites, Panaferd-AX, Tow PREPREG, sheet pallet …
  • Tzamal Medical Group Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tzamal Medical Group Ltd (Tzamal Medical) is a medical device company that manufactures and markets medical equipment, implants, disposables, surgical instruments and veterinary drugs. The company’s products include disposable products, patient monitor equipment and patient self testing equi …
  • RCL Foods Ltd. (RCL):企業の財務・戦略的SWOT分析
    RCL Foods Ltd. (RCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Alon USA Energy Inc (ALJ)-石油・ガス分野:企業M&A・提携分析
    Summary Alon USA Energy Inc (Alon USA), a subsdiary of Delek US Holdings, Inc., is a refiner and marketer of petroleum products. The products offered by the company include various grades of gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based …
  • Hite Jinro Co., Ltd:企業の戦略・SWOT・財務情報
    Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Hite Jinro Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Loblaw Companies Limited:戦略・SWOT・企業財務分析
    Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report Summary Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆